Goto T, Jay J H, Mendez M, Zubiate P, Vanstrom N, Yokoyama T
Arch Surg. 1978 Jul;113(7):817-9. doi: 10.1001/archsurg.1978.01370190039006.
Twenty-four patients had resection of their ventricular aneurysm and 29 had resection plus revascularization. Sixty percent of the patients received no blood in the heart lung machine during surgery or at any time during hospitalization. One of 24 patients with ventricular resection and two of 29 patients with resection plus revascularization died during hospitalization, for an overall mortality of 5.7%. Fifty of the 53 patients had an ejection fraction of 0.4 or less and 23 of these had an ejection fraction of 0.2 or less. Survival rate was 75.5% at four years for all 53 patients compared to only 12% of patients alive at five years with medical treatment. For the patient with a large ventricular aneurysm, resection and myocardial revascularization can be performed with a low risk even for the patient with poorly functioning residual myocardium.
24例患者进行了心室动脉瘤切除术，29例患者进行了切除术加血管重建术。60%的患者在手术期间或住院期间的任何时候未在心肺机中输血。24例心室切除术患者中有1例，29例切除术加血管重建术患者中有2例在住院期间死亡，总死亡率为5.7%。53例患者中有50例射血分数为0.4或更低，其中23例射血分数为0.2或更低。所有53例患者的四年生存率为75.5%，而药物治疗的患者五年生存率仅为12%。对于患有大型心室动脉瘤的患者，即使是残余心肌功能较差的患者，进行切除术和心肌血管重建术的风险也较低。
